Pregled bibliografske jedinice broj: 1143080
Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches
Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches // BMJ Open Diabetes Research & Care, 9 (2021), 1; 002263, 9 doi:10.1136/bmjdrc-2021-002263 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1143080 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Plasma N-glycome shows continuous deterioration as
the diagnosis of insulin resistance approaches
Autori
Cvetko, Ana ; Mangino, Massimo ; Tijardović, Marko ; Kifer, Domagoj ; Falchi, Mario ; Keser, Toma ; Perola, Markus ; Spector, Tim D ; Lauc, Gordan ; Menni, Cristina ; Gornik, Olga
Izvornik
BMJ Open Diabetes Research & Care (2052-4897) 9
(2021), 1;
002263, 9
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
insulin resistance ; plasma N-glycosylation ; type 2 diabetes mellitus ; TwinsUK
Sažetak
Introduction: Prediction of type 2 diabetes mellitus (T2DM) and its preceding factors, such as insulin resistance (IR), is of great importance as it may allow delay or prevention of onset of the disease. Plasma protein N-glycome has emerged as a promising predictive biomarker. In a prospective longitudinal study, we included patients with a first diagnosis of impaired glucose metabolism (IR or T2DM) to investigate the N-glycosylation’s predictive value years before diabetes development. Research design and methods: Plasma protein N- glycome was profiled by hydrophilic interaction ultra-performance liquid chromatography in 534 TwinsUK participants free from disease at baseline. This included 89 participants with incident diagnosis of IR or T2DM during the follow-up period (7.14±3.04 years) whose last sample prior to diagnosis was compared using general linear regression with 445 age- matched unrelated controls. Findings were replicated in an independent cohort. Changes in N- glycome have also been presented in connection with time to diagnosis. Results: Eight groups of plasma N-glycans were different between incident IR or T2DM cases and controls (p<0.05) after adjusting for multiple testing using Benjamini- Hochberg correction. These differences were noticeable up to 10 years prior to diagnosis and are changing continuously as becoming more expressed toward the diagnosis. The prediction model was built using significant glycan traits, displaying a discriminative performance with an area under the receiver operating characteristic curve of 0.77. Conclusions: In addition to previous studies, we showed the diagnostic potential of plasma N- glycome in the prediction of both IR and T2DM development years before the clinical manifestation and indicated the continuous deterioration of N-glycome toward the diagnosis.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
GENOS d.o.o.
Profili:
Olga Gornik Kljaić
(autor)
Domagoj Kifer
(autor)
Ana Cvetko
(autor)
Gordan Lauc
(autor)
Marko Tijardović
(autor)
Toma Keser
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE